Sex differences in quality of health care related to ischemic heart disease prevention in patients with diabetes: the translating research into action for Diabetes (TRIAD) study, 2000-2001.
暂无分享,去创建一个
[1] M. Harris,et al. Diabetes and decline in heart disease mortality in US adults. , 1999, JAMA.
[2] E. Barrett-Connor,et al. Dyslipidemia and ischemic heart disease mortality among men and women with diabetes. , 1994, Circulation.
[3] E. Barrett-Connor,et al. Chapter 19 Heart Disease and Diabetes , 2022 .
[4] S. Grundy,et al. Plasma lipids and diabetes mellitus in an adult community. , 1982, American journal of epidemiology.
[5] S. Yusuf,et al. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators. , 2000 .
[6] Clyne,et al. Hypertension in Diabetes Study (HDS): I. Prevalence of hypertension in newly presenting type 2 diabetic patients and the association with risk factors for cardiovascular and diabetic complications. , 1993, Journal of hypertension.
[7] M Rosenthal,et al. Sex difference in the effects of sociocultural status on diabetes and cardiovascular risk factors in Mexican Americans. The San Antonio Heart Study. , 1984, American journal of epidemiology.
[8] J. Hippisley-Cox,et al. Sex inequalities in ischaemic heart disease in general practice: cross sectional survey , 2001, BMJ : British Medical Journal.
[9] C. Sueta,et al. Trends in lipid management among patients with coronary artery disease: has diabetes received the attention it deserves? , 2003, Diabetes care.
[10] J. Stengård,et al. Antibodies to glutamic acid decarboxylase as predictors of insulin-dependent diabetes mellitus before clinical onset of disease , 1994, The Lancet.
[11] W. K. Jones,et al. Awareness, perception, and knowledge of heart disease risk and prevention among women in the United States. American Heart Association Women's Heart Disease and Stroke Campaign Task Force. , 2000, Archives of family medicine.
[12] Walker,et al. Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients , 1994 .
[13] J. Manson,et al. The primary prevention of coronary heart disease in women. , 1995, The New England journal of medicine.
[14] J. Slattery,et al. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). 1994. , 1994, Atherosclerosis. Supplements.
[15] K. Narayan,et al. Aspirin use among adults with diabetes: estimates from the Third National Health and Nutrition Examination Survey. , 2001, Diabetes care.
[16] Lisa M. Schwartz,et al. Treatment and health outcomes of women and men in a cohort with coronary artery disease. , 1997, Archives of internal medicine.